Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Change in Accured Expenses (2024 - 2025)

Profound Medical has reported Change in Accured Expenses over the past 2 years, most recently at $40000.0 for Q4 2025.

  • Quarterly results put Change in Accured Expenses at $40000.0 for Q4 2025, down 93.81% from a year ago — trailing twelve months through Dec 2025 was $378000.0 (down 53.62% YoY), and the annual figure for FY2025 was $378000.0, down 53.62%.
  • Change in Accured Expenses for Q4 2025 was $40000.0 at Profound Medical, up from -$207000.0 in the prior quarter.
  • Over the last five years, Change in Accured Expenses for PROF hit a ceiling of $676000.0 in Q3 2024 and a floor of -$570000.0 in Q1 2024.